Welcome to the detailed analysis for endpts.com. This domain is officially recognized as Endpoints News – Biotech and pharma business news, with a focus on the science, people and money that drive the industry.. According to their official web presence, their primary focus is: "Biotech and pharma business news, with a focus on the science, people and money that drive the industry.".
"After a lower court rejected Teva's case last fall, a federal appeals court has revived part of the drugmaker’s lawsuit against Medicare negotiations."
"Sandoz unveiled a direct-to-consumer platform, starting off with a single medication for now as the generic drugmaker adopts a system that several brand-name manufacturers are using to cut ..."
"Biogen’s monoclonal antibody felzartamab was approved in China for the treatment of multiple myeloma."
"Hims & Hers is laying the groundwork to offer access to six banned consumer wellness peptides, should the FDA lift restrictions that prevent compounding pharmacies from making them."
By comparing endpts.com to other leading websites in its niche, marketers and researchers can identify key traffic sources and growth opportunities. Explore our related resources below to find websites similar to endpts.com.
Yes, according to our latest analysis, we detected a valid SSL certificate ensuring a secure connection.
As of August 20, 2026, endpts.com holds an estimated domain authority score of 74/100 based on our VisitRank tracking algorithms.
You can find the best alternatives and similar sites to endpts.com in our explore section, which includes competitors in the E-commerce & Retail sector.
Common Misspellings & Typo Domains for endpts.com: